Aging · 2019 · 69 citations · 25 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer TranscriptomicsKidney CancerMicrorna-mediated RegulationNoncoding Rna BiologyRenal Cell CarcinomaRna InterferenceAntisense Rna RegulationAntisense RnasCancer BioinformaticsDual-luciferase AssaysLuciferase Reporter AssaysLuciferase ReportersNoncoding Rna-mediated Gene RegulationRna Immunoprecipitation
Accumulating evidence reveals the principal role of long noncoding RNAs in the progression of clear cell renal cell carcinoma (ccRCC). However, little is known about the underlying mechanism of ADAM metallopeptidase with thrombospondin type 1 motif, 9 antisense RNA 2 (ADAMTS9-AS2) in ccRCC. Here, bioinformatics analyses verified ADAMTS9-AS2 is a long noncoding RNA and its high expression was associated with better prognosis of ccRCC. ADAMTS9-AS2 was clearly downregulated in ccRCC clinical samples and cell lines. Clinical data showed low-expressed ADAMTS9-AS2 was correlated with worse overall survival in ccRCC patients. Next, miR-27a-3p was identified as an inhibitory target of ADAMTS9-AS2 by dual-luciferase reporter and RNA immunoprecipitation assays. Both overexpressed ADAMTS9-AS2 and underexpressed miR-27a-3p in ccRCC cell lines led to the inhibition of cell proliferation and the reduction of chemoresistance. Additionally, Forkhead Box Protein O1 (FOXO1) was confirmed as the inhibitory target of miR-27a-3p. Induced by ADAMTS9-AS2 overexpression, cell proliferation and chemoresistance exhibited an obvious reduction, FOXO1 expression showed an evident increase, but all were reversed after miR-27a-3p was simultaneously overexpressed. Collectively, these results suggest ADAMTS9-AS2 inhibits the progression and impairs the chemoresistance of ccRCC via miR-27a-3p-mediated regulation of FOXO1 and may serve as a prognostic biomarker and therapeutic target for ccRCC.
25
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Ji‐hang Yuan, Fu Yang, Fang Wang et al. · Cancer Cell · 2014 · 1.6K citations · Full text
Xue Yang, Jee Hoon Song, Yulan Cheng et al. · Gut · 2013 · 211 citations